Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice

J. Kassa, K. Musilek, M. Koomlova, J. Bajgar

. 2012 ; 110 (4) : 322-326.

Language English Country Denmark

Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12034889

The ability of three newly developed reversible inhibitors of acetylcholinesterase (AChE) (K298, K344 and K474) and currently available carbamate pyridostigmine to increase the resistance of mice against soman and the efficacy of antidotal treatment of soman-poisoned mice was compared. Neither pyridostigmine nor new reversible inhibitors of AChE were able to increase the LD(50) value of soman. Thus, the pharmacological pre-treatment with pyridostigmine or newly synthesized inhibitors of AChE was not able to protect mice against soman-induced lethal acute toxicity. The pharmacological pre-treatment with pyridostigmine alone or with K474 was able to slightly increase the efficacy of antidotal treatment (the oxime HI-6 in combination with atropine) of soman-poisoned mice, but the increase in the efficacy of antidotal treatment was not significant. The other newly developed reversible inhibitors of AChF (K298, K344) were completely ineffective. These findings demonstrate that pharmacological pre-treatment of soman-poisoned mice with tested reversible inhibitors of AChF is not promising.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034889
003      
CZ-PrNML
005      
20160728152747.0
007      
ta
008      
121023s2012 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/j.1742-7843.2011.00808.x $2 doi
035    __
$a (PubMed)21981462
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Kassa, Jiří, $u Department of Toxicology, Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic. kassa@pmfhk.cz $d 1956- $7 mzk2003181395
245    12
$a A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice / $c J. Kassa, K. Musilek, M. Koomlova, J. Bajgar
520    9_
$a The ability of three newly developed reversible inhibitors of acetylcholinesterase (AChE) (K298, K344 and K474) and currently available carbamate pyridostigmine to increase the resistance of mice against soman and the efficacy of antidotal treatment of soman-poisoned mice was compared. Neither pyridostigmine nor new reversible inhibitors of AChE were able to increase the LD(50) value of soman. Thus, the pharmacological pre-treatment with pyridostigmine or newly synthesized inhibitors of AChE was not able to protect mice against soman-induced lethal acute toxicity. The pharmacological pre-treatment with pyridostigmine alone or with K474 was able to slightly increase the efficacy of antidotal treatment (the oxime HI-6 in combination with atropine) of soman-poisoned mice, but the increase in the efficacy of antidotal treatment was not significant. The other newly developed reversible inhibitors of AChF (K298, K344) were completely ineffective. These findings demonstrate that pharmacological pre-treatment of soman-poisoned mice with tested reversible inhibitors of AChF is not promising.
650    _2
$a zvířata $7 D000818
650    _2
$a antidota $x aplikace a dávkování $x farmakologie $7 D000931
650    _2
$a atropin $x aplikace a dávkování $x farmakologie $7 D001285
650    _2
$a chemické bojové látky $x otrava $7 D002619
650    _2
$a cholinesterasové inhibitory $x aplikace a dávkování $x farmakologie $7 D002800
650    _2
$a reaktivátory cholinesterasy $x aplikace a dávkování $x farmakologie $7 D002801
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a isochinoliny $x aplikace a dávkování $x farmakologie $7 D007546
650    _2
$a LD50 $7 D007928
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a oximy $x aplikace a dávkování $x farmakologie $7 D010091
650    _2
$a pyridinové sloučeniny $x aplikace a dávkování $x farmakologie $7 D011726
650    _2
$a pyridostigmin-bromid $x aplikace a dávkování $x farmakologie $7 D011729
650    _2
$a soman $x aplikace a dávkování $x otrava $7 D012999
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Musílek, Kamil, $d 1980- $7 xx0135628 $u Department of Toxicology, Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic
700    1_
$a Koomlova, Marketa $u Department of Toxicology, Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic
700    1_
$a Bajgar, Jiří, $d 1944- $7 js20020122033 $u Department of Toxicology, Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic
773    0_
$w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 110, č. 4 (2012), s. 322-326
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21981462 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20160728152548 $b ABA008
999    __
$a ok $b bmc $g 956899 $s 792386
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 110 $c 4 $d 322-326 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
LZP    __
$b NLK112 $a Pubmed-20121023

Find record

Citation metrics

Archiving options